题名 | Implication of serum soluble IL-2 receptor α in type 2 diabetes mellitus |
作者 | |
发表日期 | 2024-12-20 |
发表期刊 | JOURNAL OF DIABETES AND METABOLIC DISORDERS 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | Type 2 diabetes mellitus Diabetic kidney disease IL-2 receptor |
其他关键词 | KIDNEY-DISEASE ; DIAGNOSIS ; INTERLEUKIN-2-RECEPTOR ; ADIPOGENESIS ; PROGRESSION ; GAMMA ; CELLS |
摘要 | ObjectivesThe aim of this study was to determine the association of serum soluble IL-2 receptor alpha (sIL-2RA) with T2DM-related characteristics and complications. MethodsSerum sIL-2RA levels were determined in 156 T2DM patients, and the association with T2DM-related characteristics and complications was evaluated. ResultsSerum sIL-2RA levels were significantly increased in T2DM patients with diabetic kidney disease (DKD) (median, IQR, 1434.9, 958.1-1896.0, pg/ml), in comparison with those without DKD (median, IQR, 851.2, 660.2-1089.9, pg/ml)(P < 0.001). The ROC analysis revealed good performance of sIL-2RA for identifying DKD, with the areas under the curve of 0.789 (95%CI of 0.711-0.867, P < 0.001). The correlation analyses showed significantly positive correlations of serum sIL-2RA with urea (r = 0.458, P < 0.001), creatinine (r = 0.508, P < 0.001) and uACR (r = 0.469, P < 0.001), and negative correlation with eGFR (r=-0.561, P < 0.001). The multivariate analyses showed that serum sIL-2RA was independently associated with the increased risks of DKD (OR, 95%CI, 6.539, 1.401-30.529, P = 0.017) and DR (OR, 95%CI, 3.606, 1.073-12.114, P = 0.038). Additionally, serum sIL-2RA was significantly associated with inflammatory indicators in DKD patients, and with metablic indicators in non-DKD patients (all P < 0.05). ConclusionSerum sIL-2RA may be closely associated with inflammation, glucose and lipid metabolisms, DKD and DR risks in T2DM. Furthermore, it may be a potential biomarker for T2DM-related micro-vascular complications. |
资助项目 | Medical Health Science and Technology Project of Zhejiang Provincial Health Commission [2024KY532]; Taizhou Science and Technology Project [22ywa31] |
出版者 | SPRINGER INT PUBL AG |
ISSN | 2251-6581 |
EISSN | 2251-6581 |
卷号 | 24期号:1 |
DOI | 10.1007/s40200-024-01536-x |
页数 | 10 |
WOS类目 | Endocrinology & Metabolism |
WOS研究方向 | Endocrinology & Metabolism |
WOS记录号 | WOS:001381132600006 |
收录类别 | ESCI ; SCOPUS ; PUBMED |
URL | 查看原文 |
PubMed ID | 39712341 |
SCOPUSEID | 2-s2.0-85212697468 |
通讯作者地址 | [Li, Jie;Yang, Zaixing]Wenzhou Med Univ, Taizhou Peoples Hosp 1, Huangyan Hosp, Dept Lab Med, Taizhou, Peoples R China. |
Scopus学科分类 | Internal Medicine;Endocrinology, Diabetes and Metabolism |
SCOPUS_ID | SCOPUS_ID:85212697468 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/224880 |
专题 | 其他_附属黄岩医院(台州市第一人民医院) |
通讯作者 | Li, Jie; Yang, Zaixing |
作者单位 | 1.Wenzhou Med Univ, Taizhou Peoples Hosp 1, Huangyan Hosp, Dept Lab Med, Taizhou, Peoples R China; 2.Fujian Med Univ, Mengchao Hepatobiliary Hosp, Dept Radiat Oncol, Fuzhou, Peoples R China; 3.Xuzhou Med Univ, Peoples Hosp Changshu 2, Dept Sci & Technol, Key Lab,Affiliated Changshu Hosp, Changshu, Jiangshu, Peoples R China; 4.Wenzhou Med Univ, Taizhou Peoples Hosp 1, Dept Oncol, Huangyan Hosp, Taizhou, Peoples R China |
第一作者单位 | 其他_附属黄岩医院(台州市第一人民医院) |
通讯作者单位 | 其他_附属黄岩医院(台州市第一人民医院) |
第一作者的第一单位 | 其他_附属黄岩医院(台州市第一人民医院) |
推荐引用方式 GB/T 7714 | Zhao, Bing,Zhang, Miaomiao,Liao, Shaoguang,et al. Implication of serum soluble IL-2 receptor α in type 2 diabetes mellitus[J]. JOURNAL OF DIABETES AND METABOLIC DISORDERS,2024,24(1). |
APA | Zhao, Bing, Zhang, Miaomiao, Liao, Shaoguang, Jiang, Tingwang, Li, Jie, & Yang, Zaixing. (2024). Implication of serum soluble IL-2 receptor α in type 2 diabetes mellitus. JOURNAL OF DIABETES AND METABOLIC DISORDERS, 24(1). |
MLA | Zhao, Bing,et al."Implication of serum soluble IL-2 receptor α in type 2 diabetes mellitus".JOURNAL OF DIABETES AND METABOLIC DISORDERS 24.1(2024). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论